INTRODUCTION
Lipid rafts, the nanoscale lipid domains, in a plasma membrane of living cells play a
crucial organizing role in cellular signaling and regulatory cascades
1-6
. Micrometer-sized lipid
domains with a liquid-crystal-like order are easily observable by optical fluorescence microscopy
in model membranes made of heterogeneous lipid mixtures
4, 7-10
. However, their cellular
counterparts are expected to be much smaller, nanometer-sized, making them only resolvable by
electron and atomic force microscopy techniques
11-14
. In a cell, many membrane proteins
permanently reside in raft membrane domains, which is essential for their function
5, 15-19
. Ras, a
small monomeric GTPase, provides an intriguing example of a membrane protein that dynamically
switches its nanodomain affinity upon transition between its active and inactive functional states
(bound to GTP and GDP, respectively)
20-23
.
Ras is a small monomeric GTPase involved in regulation of cell growth, proliferation and
differentiation
24
. Mutations in the Ras genes are observed in up to 25% of all human cancers, which
makes Ras one of the major targets for cancer therapy
25-28
. Ras consists of a GTPase catalytic
domain (G domain) binding guanine nucleotides and the C-terminal peptide anchored to the inner
leaflet of plasma membrane through a posttranslational lipidation motif
29-31
. Membrane attachment
is crucial to Ras function: most effector proteins can only be activated by Ras-GTP when it is
attached to the membrane surface
25, 32
.
Ras proteins are represented by three Ras isoforms with a high degree of homology and
nearly 90% sequence identity in the N-terminal GTPase domain
33
. The remaining C-terminal 22-
23 amino acids, known as the hyper-variable region, have no sequence similarity except for the
conserved CAAX motif necessary for membrane targeting
34
. The variability of the C-terminal
sequences of the Ras isoforms leads to different processing patterns in the cell. All Ras isoforms
.CC-BY-NC-ND 4.0 International licenseunder a
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available